Cardiff Oncology, Inc. · Brief

Next report

3 days

Nov 5 · after closeest.Q3 FY26

Expected move

No implied move.

8 reportsHistory

0 of 8≥ implied

Aug 8 '24±34.4%▲+11.74%×0.34

Nov 7 '24±37.4%▼−24.69%×0.66

Feb 27 '25±22.0%▲+4.43%×0.20

May 8 '25±15.4%▲+1.14%×0.07

Jul 29 '25±56.5%▼−24.77%×0.44

Q3 FY25±13.7%▼−2.67%×0.19

Q1 FY26±15.5%▼−3.47%×0.22

Q2 FY26±17.0%▼−5.67%×0.33

quarterimplied−60%0+60%realized×

Q2 FY26±17.0%▼−5.67%×0.33

Q1 FY26±15.5%▼−3.47%×0.22

Q3 FY25±13.7%▼−2.67%×0.19

Jul '25±56.5%▼−24.77%×0.44

May '25±15.4%▲+1.14%×0.07

Feb '25±22.0%▲+4.43%×0.20

2 older reports

Nov '24±37.4%▼−24.69%×0.66

Aug '24±34.4%▲+11.74%×0.34

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 5 report · est.

Bull2 of 3

3disclosed supplier and customer ties in SEC filingsSEC filings

102managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 3

8 of 8recent reports where the move came in under the options implied rangeEarnings history

9 of 21of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

AI captions · Sep 16 '26once per report · top 2 per case

CRDF report session

No linked exposure.

Oct 22impliedImplied move: ±20.2% into Nov 5 earnings (Oct 22 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.